Abstract
In a randomized double-blind trial of aerosolized ribavirin for the treatment of influenza B virus infection, no significant difference was found in the febrile course or symptom score of the ribavirin-treated versus placebo-treated patients. The apparent lack of efficacy in this study as compared with that in previous studies is unexplained.
Publication types
-
Clinical Trial
-
Randomized Controlled Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Aerosols
-
Body Temperature
-
Clinical Trials as Topic
-
Disease Outbreaks*
-
Double-Blind Method
-
Humans
-
Influenza B virus / growth & development
-
Influenza, Human / drug therapy*
-
Random Allocation
-
Ribavirin / administration & dosage
-
Ribavirin / therapeutic use*
-
Ribonucleosides / therapeutic use*
Substances
-
Aerosols
-
Ribonucleosides
-
Ribavirin